Atlas Trials

Phase I Trial of Intramural Injection of DTI-015 for Recurrent Malignant Gliomas

Clinical trial NCT00038441 · COMPLETED

Trial details

NCT number
NCT00038441
Sponsor
M.D. Anderson Cancer Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
GliomaBrain Neoplasms
Start date
1995-09-01
Primary completion
2003-02-01
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.